Kate Zhong

Adjunct Professor, Department of Brain Health
Founder, Brainnovation Initiative
CEO, CNS Innovations LLC
Expertise: Geriatrics, Neurodegenerative brain diseases, Alzheimer’s disease, Clinical trials, Neuroscience, Neurotherapeutics


Kate Zhong — an adjunct professor in UNLV’s Department of Brian Health — is a geriatric psychiatrist, pharmacologist, and brain health advocate. Zhong is the founder of Brainnovation Initiative and chief executive officer of CNS Innovations LLC, a company that provides consultation services to advance prevention, diagnosis, and treatment of Alzheimer’s disease.

Before joining UNLV’s faculty, Zhong served as the chief strategy officer for Global Alzheimer’s Platform, a foundation devoted to improving and accelerating clinical trials for Alzheimer’s disease. From 2010-2016, she was the senior director of clinical research for the Cleveland Clinic Lou Ruvo Center for Brain Health, where she led the development of programs treating patients with neurodegenerative diseases such as Parkinson’s disease. She is a founding member of AARP Global Council on Brain Health and serves on multiple boards in Nevada and beyond.

Zhong is a worldwide respected expert on brain health, having served as a scientific consultant for multiple pharmaceutical and biotech companies in the United States, Canada, and Asia. She was named a “Woman to Watch” and ”Alzheimer’s Ambassador” by Vegas Inc. Magazine, as well as honored with the “Healthcare Headliner Research Award” for her creation of Cleveland Clinic's healthybrains.org and the Health Brain Index. Zhong was featured in the PBS documentary “MAKERS: Women Who Make America,” profiling her as one of Nevada’s most influential women.


  • M.D., West China University of Medical Sciences
  • M.A., Pharmacology, University of Toronto
  • Psychiatric Residency Program, University of Toronto

Search For Other Experts On

health & medicine, science & technology

Kate Zhong In The News

Chic Compass
Dr. Kate Zhong & Dr. Jeffrey Cummings: The Like-Minded Alzheimer's Ambassadors of Las Vegas
K.S.N.V. T.V. News 3
The first drug to treat Alzheimer’s disease in 18 years, which was extensively researched at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, has won approval from the Food and Drug Administration.
K.T.N.V. T.V. ABC 13
For the first time in nearly 20 years, the FDA approved a drug for the treatment of Alzheimer's disease.
An all-star panel of experts on women’s brain health and wellness led a 90-minute virtual event viewed by more than a thousand people on Dec. 3.